Mutations in components of the RAS-MAPK pathway provide a unifying mechanism for several phenotypically overlapping, yet clinically distinct human 'neuro-cardio-facial-cutaneous' (NCFC) syndromes. These rare diseases may provide new insights into the regulation of this pathway and its role in various cancers.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
68,37 €
only 5,70 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

Katie Ris
References
Cichowski, K. & Jacks, T. Cell 104, 593–604 (2001).
Tartaglia, M. & Gelb, B.D. Annu. Rev. Genomics Hum. Genet. 6, 45–68 (2005).
Aoki, Y. et al. Nat. Genet. 37, 1038–1040 (2005).
Rodriguez-Viciana, P. et al. Science published online 26 January 2006 (10.1126/science.1124642).
Niihori, T. et al. Nat. Genet. 38, 294–296 (2006).
Schubbert, S. et al. Nat. Genet. 38, 331–336 (2006).
Kolch, W. Nat. Rev. Mol. Cell. Biol. 6, 827–837 (2005).
Keilhack, H., David, F.S., McGregor, M., Cantley, L.C. & Neel, B.G. J. Biol. Chem. 280, 30984–30993 (2005).
Wan, P. T. et al. Cell 116, 855–867 (2004).
Garnett, M. J., Rana, S., Paterson, H., Barford, D. & Marais, R. Mol. Cell 20, 963–969 (2005).
Kontaridis, M.I., Swanson, K.D., David, F.S., Barford, D. & Neel, B.G. J. Biol. Chem. published online 25 December 2005 (10.1074/jbc.M513068200).
Araki, T. et al. Nat. Med. 10, 849–857 (2004).
Mor, A. & Philips, M.R. Annu. Rev. Immunol. published online 16 January 2006 (10.1146/annurev.immunol.24.021605.090723).
Inoki, K., Corradetti, M.N. & Guan, K.L. Nat. Genet. 37, 19–24 (2005).
Sebolt-Leopold, J.S. & Herrera, R. Nat. Rev. Cancer 4, 937–947 (2004).
Solit, D.B. et al. Nature 439, 358–362 (2006).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Bentires-Alj, M., Kontaridis, M. & Neel, B. Stops along the RAS pathway in human genetic disease. Nat Med 12, 283–285 (2006). https://doi.org/10.1038/nm0306-283
Issue Date:
DOI: https://doi.org/10.1038/nm0306-283
Further reading
-
The impact of RASopathy-associated mutations on CNS development in mice and humans
Molecular Brain (2019)
-
Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis
Journal of Biomedical Science (2018)
-
Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models
Scientific Reports (2017)
-
Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities
Orphanet Journal of Rare Diseases (2016)
-
Feedback activation of neurofibromin terminates growth factor-induced Ras activation
Cell Communication and Signaling (2016)